Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
Tempus AI, Inc. - Class A (TEM)
Company Research
Source: Business Wire
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is scheduled to exhibit 4 abstracts at the American College of Cardiology (ACC) Annual Meeting, which convenes from March 29-31 in Chicago, Illinois. This is the first year that Tempus is presenting research, all of which highlights the application of AI to support clinicians in delivering personalized care.“Tempus is committed to enabling clinicians to provide better, guideline-recommended care to patients who may have undiagnosed or undertreated cardiovascular disease,” said Brandon Fornwalt, MD, PhD, Senior Vice President of Cardiology at Tempus. “Through our vast connected network of providers and ability to deliver AI-enabled insights at scale, we can help clinicians close care gaps for patients in a way that wasn’t possible before.”Highlights from Tempus’ abstracts include:Abstract 184: Developmen
Show less
Read more
Impact Snapshot
Event Time:
TEM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEM alerts
High impacting Tempus AI, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
TEM
News
- Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up [Yahoo! Finance]Yahoo! Finance
- Tempus AI (NASDAQ:TEM) had its price target lowered by analysts at JPMorgan Chase & Co. from $85.00 to $80.00. They now have a "neutral" rating on the stock.MarketBeat
- Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now? [Yahoo! Finance]Yahoo! Finance
- Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer SymposiumBusiness Wire
- Tempus AI, Inc. (TEM): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
TEM
Earnings
- 11/4/25 - Beat
TEM
Sec Filings
- 12/18/25 - Form 144
- 12/18/25 - Form 4
- 12/16/25 - Form 144
- TEM's page on the SEC website